Lund, Sweden

Stephan Bjork

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Stephan Bjork

Introduction

Stephan Bjork is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of glycan analysis through his innovative patents. With a total of 2 patents, his work focuses on enzymes and methods that enhance the study of glycoproteins.

Latest Patents

His latest patents include "Enzymes for glycan analysis," which relates to enzymes and combinations useful for studying glycoproteins. This invention particularly emphasizes a sialidase composition that includes an additional protease and/or glycosidase, specifically targeting O-glycoproteins. Another significant patent is "Protease and binding polypeptide for O-glycoproteins," which introduces a novel endoprotease and its mutants that possess binding capabilities while lacking or having reduced hydrolyzing activity. This invention is crucial for methods aimed at studying and isolating O-linked glycoproteins.

Career Highlights

Stephan Bjork is associated with Genovis AB, a company that specializes in providing innovative solutions for glycan analysis. His work at Genovis AB has positioned him as a key player in the field of biotechnology, particularly in the study of glycoproteins.

Collaborations

He collaborates with talented individuals such as Fredrik Leo and Malin Mejare, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Stephan Bjork's contributions to glycan analysis through his patents and work at Genovis AB highlight his role as an influential inventor in the biotechnology sector. His innovative approaches continue to advance the understanding of glycoproteins and their applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…